Schedule 13G ownership disclosure

10X Genomics Inc

Common Stock · CUSIP: 88025U109

Event date: 2025-09-30

Filing-level shares
13,274,332
Percent of class
11.60%
  • The Vanguard Group

    Shares: 13,274,332 · Class: 11.60%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-25-000030
Form type
SCHEDULE 13G/A
Filer
10x Genomics, Inc.
CIK
CIK 1770787
Filed
Oct 30, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub